Cell and gene therapies, gene editing, and tissue-based treatments are redefining what's possible in medicine. Explore the cutting-edge science and real-world impact of the technologies shaping the future of human health.
ARM unites and advocates for the cell and gene therapy ecosystem—advancing policy, innovation, and patient access.
Cell and gene therapies are ‘living’ medicines that harness natural biological processes to repair cells and genes, thereby durably treating and potentially curing disease.
Inserts or replaces genetic material to correct inherited conditions or treat acquired diseases at the molecular level.
Technologies like CRISPR enable precise, targeted changes to the genome—offering durable solutions for monogenic diseases.
Patient or donor-derived cells used to restore, replace, or modulate function—already in use for cancer, immune disorders, and other diseases.
Regenerative products that rebuild, replace, or support damaged tissues and organs.
Dozens of cell and gene therapies are already approved worldwide, and reaching patients—delivering real-world impact across diverse disease areas.
Cell and gene therapies are delivering breakthroughs across hematology, neurology, oncology, immune disorders, and more.
Sign up for ARM’s weekly newsletter on sector news and alerts for events, reports, and other engagement opportunities.
